LBA1 A Randomized Multicenter Open Label Phase III Trial Comparing Enzalutamide Vs a Combination of Radium-223 (ra223) and Enzalutamide in Asymptomatic or Mildly Symptomatic Patients with Bone Metastatic Castration-Resistant Prostate Cancer (mcrpc): First Results of EORTC-GUCG 1333/PEACE-3
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要